We used a live-attenuated L. monocytogenes-based vaccine expressing an altered peptide ligand of the class I -restricted peptide AH1, which is derived from the endogenous self-antigen gp70 that is also expressed by 4T1 cancer cells [25]. The gene discussed is EMB; the disease is cancer.